Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19

NCT04476979 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

453

Enrollment

OTHER

Sponsor class

Conditions

Coronavirus Infection
SARS (Severe Acute Respiratory Syndrome)
Virus Diseases
Coronaviridae Infections
Nidovirales Infections
RNA Virus Infections
Respiratory Tract Infections
Respiratory Tract Disease

Interventions

DRUG: Tocilizumab
DRUG: Dexamethasone

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]